| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 81.9 | 97.5 | 23.4 |
| Other income | 1.5 | 0.8 | 7.5 |
| Total income | 83.4 | 98.3 | 30.9 |
| Profit before exceptional items & tax | 7.8 | -7.6 | 10.1 |
| Profit before tax | 7.8 | -7.6 | 10.1 |
| Net profit | 3.8 | -12.4 | 4.9 |
| Operating margin | 9.4% | -7.7% | 32.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -22.40% |
|---|---|
| Revenue, year on year | +250.00% |
| Operating profit, year on year | +142.30% |
| Operating profit, quarter on quarter | +175.00% |
BSE results filing, NSE: FISCHER. Figures extracted from the filing.
Fischer Medical Ventures Ltd: key numbers
- Share price
- ₹34.29
- Market cap
- ₹2,375 Cr
- Revenue (annual)
- ₹308.6 Cr
- Net profit (annual)
- ₹31.02 Cr
- P/E (TTM)
- 79.7×Sector 37.5×
- Promoter holding
- 63.08%+0.93% QoQ
- FII holding
- 5.57%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fischer Medical Ventures Ltd
All →Fischer Medical Ventures Annual Report
The company issued a corrigendum to its FY 2025-26 Annual Report. This update corrects financial highlights, auditor report details, and capital management tables.
Fischer Medical Ventures Acquisition Worth ₹49.88 Cr
Fischer Medical Ventures will invest ₹49.88 Crore into its three material wholly-owned subsidiaries via rights issues to support capital expansion.
- Value
- ₹49.88 Cr
Fischer Medical Ventures Business Update
Fischer Medical Ventures published a Chairman's Letter outlining its Radiology, Preventive Healthcare and Wellness segments plus Indonesia and Philippines deployments. No new transaction, order or capital event is announced.
Fischer Medical Ventures Annual Report
Fischer Medical Ventures Limited has submitted its Annual Report for the financial year 2025-2026 as per SEBI regulations. The document is available on the company website.
Fischer Medical Ventures Annual General Meeting
Fischer Medical Ventures Limited has scheduled its 33rd Annual General Meeting on September 29, 2026, through video conferencing. The company also announced the e-voting and book closure dates.
Fischer Medical Ventures Investor Presentation: Key Takeaways
Fischer Medical Ventures is building an AI-enabled healthcare platform integrating medical imaging, screening, and hospital digitization. Strategy focuses on vertically integrated IP across magnets, coils, and AI diagnostics.